Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/11157038

J. Clin. Oncol. 2001 Feb 1 19 3 843-50

Download in:

View as

General Info

PMID
11157038